Antigua and Barbuda vs Ireland: Hypertension effective treatment coverage (controlled hypertension)
Antigua and Barbuda
23.2%
in 2019
Ireland
23.8%
in 2019
Antigua and Barbuda rank
60th
Ireland rank
57th
Hypertension effective treatment coverage (controlled hypertension) over time
- Antigua and Barbuda
- Ireland
How they compare
Ireland currently reports 23.8% against 23.2% in Antigua and Barbuda, a difference of 0.6%.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Antigua and Barbuda ahead.
Antigua and Barbuda ranks 60th and Ireland ranks 57th of 193 countries.
Across the 3 decades both report, Antigua and Barbuda averaged higher in 2 and Ireland in 1.
Head to head by decade
| Decade | Antigua and Barbuda | Ireland | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 8.0% | 6.3% | 1.7% | Antigua and Barbuda |
| 2000s | 15.0% | 13.2% | 1.8% | Antigua and Barbuda |
| 2010s | 21.6% | 21.7% | 0.1% | Ireland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension effective treatment coverage (controlled hypertension), Antigua and Barbuda or Ireland?
- Ireland, at 23.8% against 23.2% in Antigua and Barbuda as of 2019.
- What is the difference in hypertension effective treatment coverage (controlled hypertension) between Antigua and Barbuda and Ireland?
- 0.6%, with Ireland ahead.
- How many years of comparable data are there for Antigua and Barbuda and Ireland?
- 30 years are reported by both, from 1990 to 2019.
- How do Antigua and Barbuda and Ireland rank globally for hypertension effective treatment coverage (controlled hypertension)?
- Antigua and Barbuda ranks 60th and Ireland ranks 57th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.